dual orexin receptor GPCR antagonist
Ph. III efficacy for insomnia, oral 25-50 mg
from optimization of prior clinical candidate
ChemMedChem., Oct. 28, 2020
Idorsia Pharmaceuticals, Allschwil, CH
daridorexant
1 min read
Idorsia clinical dual orexin receptor GPCR antagonist
Search By Structure
- LY3502970
- S64315
- daridorexant
- “peptide 78”
- BMS-986144
- MLT-985
- EB-42486
- “compound 4d”
- “compound 60b”
- “compound 15a”
- “compound 31”
- “compound 36”
- BCPyr
- “compound 4j”
Molecules of the Month
2023
2022
2021
2020